A study investigating the role of TP53 in human NSCLC cell lines also revealed that certain TP53 mutations lead to a direct, micro-RNA-mediated upregulation of PD-L1, suggesting a mechanism to dampen proinflammatory mutational effects [24]. This evidence concerns the gene TP53 and non-small cell lung carcinoma.